#lab supply Africa

[aticolabexport]

Atico lab export, is a leading technical educational equipment manufacturer, suppliers and exporter from India. Get high quality TVET lab equipments, ISO certified for product details and price catalogue contact us at email and live chat support.

[kasdd]

Chemical Lab Supplies In South Africa | Kasd.co.za

If you're looking for the top chemical lab supplies in South Africa, head over to kasd.co.za. We offer the best customer service in the industry and the best products available. Buy the greatest lab supplies from us right now!

[zvaigzdelasas]

UK government officials attempted to suppress criticism of the United Arab Emirates and its alleged role in supplying arms to a notorious militia waging a campaign of ethnic cleansing in Sudan, sources have told the Guardian.

Claims that Foreign Office officials put pressure on African diplomats to avoid criticising the UAE over its alleged military support for Sudan’s Rapid Support Forces (RSF) will intensify scrutiny of the UK’s relationship with the Gulf state.[...]

The UAE has repeatedly denied involvement in sending military support to any of Sudan’s warring parties.[...]

Last week the Humanitarian Research Lab (HRL) at Yale University revealed images of a cargo plane flying over RSF territory near El Fasher, matching an aircraft type seen at locations in neighbouring Chad where lethal aid has allegedly been transferred to the RSF.[...]

Kholood Khair, Sudanese political analyst, said geopolitical dynamics explained any attempt to protect the UAE. “The UAE has made itself indispensable to the west, in particular the US, as a guarantor of its strategic objectives in the region,” she said.

Khair added: “The UAE has been helping the US stave off Chinese dominance in Africa by outspending Beijing and in return gets US security guarantees.”[...]

In 2013, as prime minister, Lord [David] Cameron set up a secretive Whitehall unit specifically to court the oil-rich sheikhs of the UAE, with the aim of persuading them to invest billions in the UK.

In January the defence secretary, Grant Shapps, said he expected the UK to raise tens of billions of pounds of investment from the UAE.

24 Jun 24

[reasonsforhope]

"A net-zero power system is closer than we think.

New research, published by RMI, indicates that an exponential surge in renewable energy deployment is outpacing the International Energy Agency’s most ambitious net-zero predictions for 2030. 

That’s right: Surging solar, wind, and battery capacity is now in-line with net-zero scenarios. 

“For the first time, we can, with hand on heart, say that we are potentially on the path to net zero,” Kingsmill Bond, Senior Principal at RMI, said. “We need to make sure that we continue to drive change, but there is a path and we are on it.”

And that’s really good news.

Exponential growth in renewable energy has put the global electricity system at a tipping point. What was once seen as a wildly daunting task — transitioning away from fossil fuels — is now happening at a faster pace every year. 

Based on this new research, conducted in partnership with the Bezos Earth Fund, RMI projects that solar and wind will supply over a third of all global electricity by 2030, up from about 12% today, which would surpass recent calls for a tripling of total renewable energy capacity by the end of the decade. 

Global progress in the renewable energy sector

China and Europe have been leading the way in clean energy generation, but the deployment of renewable energy has also been widely distributed across the Middle East and Africa. 

Research from Systems Change Lab shows that eight countries (Uruguay, Denmark, Lithuania, Namibia, Netherlands, Palestine, Jordan, and Chile) have already grown solar and wind power faster than what is needed to limit global warming to 1.5°C, proving that a swift switch to renewable energy is not only feasible — it’s entirely achievable. 

In order to make that switch, globally, wind and solar need to grow from 12% to 41% by 2030. Denmark, Uruguay, and Lithuania have already achieved that increase in the span of eight years.

Meanwhile, Namibia, the Netherlands, Palestine, Jordan, and Chile have grown solar and wind energy at sufficient rates for five years...

The economic impact of climate progress

Not only is this an exciting and unprecedented development for the health of the environment, but this rapid transition to clean energy includes widespread benefits, like jobs growth, more secure supply chains, and reductions in energy price inflation. 

This progress spans both developing and developed countries, all driven to accelerate renewables for a number of different reasons: adopting smart and effective policies, maintaining political commitments, lowering the costs of renewable energy, and improving energy security. 

And with exponential growth of clean energy means sharp declines in prices. This puts fossil fuels at a higher, uncompetitive cost — both financially and figuratively. 

RMI suggests that solar energy is already the cheapest form of electricity in history — and will likely halve in price by 2030, falling as low as $20/MWh in the coming years. This follows previous trends: solar and battery costs have declined 80% between 2012 and 2022, and offshore wind costs are down 73%."

-via Good Good Good, July 12, 2023

Let me repeat that:

For the first time in history, we are on an actual, provably achievable path to net zero emissions

[justforbooks]

It did not seem like a good thing when a precious consignment of human tumour samples on its way from Kampala, Uganda, to Heathrow was diverted to Manchester. When the samples finally arrived at the Middlesex hospital in London, they were swimming in murky fluid in their vials as though they had been infected with bacteria.

But when the pathologist Anthony Epstein looked at the fluid under the microscope he saw no bacteria, just individual cells that had been shaken loose from the tumours. And that was just what he needed in order to search for elusive virus particles and test his hunch that they were causing cancer.

In the early 1960s Epstein, who has died aged 102, had heard a lecture by Denis Burkitt, an Irish surgeon working in Kampala, that described strange tumours (now known as Burkitt lymphoma) growing around the jaws of children in equatorial Africa.

Intriguingly, the geographical distribution of the condition seemed to depend on temperature and rainfall, suggesting a biological cause. Epstein, who had been working with viruses that cause cancer in chickens, immediately suspected a virus might be involved, perhaps in association with another tropical disease such as malaria.

Epstein began to collaborate with Burkitt, who supplied him with tumours from children he had treated. But Epstein’s efforts to grow pieces of tumour in the laboratory and isolate a virus had all been unsuccessful until the dissociated cells arrived.

With his graduate student Yvonne Barr, he then decided to look at cultures of these cells in an electron microscope, a powerful instrument that had only recently become available in his lab.

The very first image showed a tell-tale outline that looked like one of the family of herpes viruses. It turned out to be a previously undescribed member of that family, and was given the name Epstein-Barr virus. In 1964, Epstein, Barr and Epstein’s research assistant, Bert Achong, published the first evidence that cancer in humans could be caused by a virus – to be greeted by widespread scepticism even though they went on to demonstrate that EB virus caused tumours in monkeys.

Thanks to samples supplied by Epstein, in 1970 Werner and Gertrude Henle at the Children’s hospital in Philadelphia discovered that EB virus also caused glandular fever. That made it possible to design a test for antibodies to the virus in order to confirm a diagnosis. EB virus turned out to be very common, infecting most children in early life, though it usually causes glandular fever only in older teenagers and young adults. As well as causing Burkitt lymphoma in endemic areas in Africa and Papua New Guinea, it is also associated with a cancer of the nose and throat that is the most common cancer of men in south China, as well as cancers in people whose immune systems have been compromised, such as those infected with HIV.

More recent research suggests that EB virus might also be involved in some cases of multiple sclerosis, and that people who have previously had glandular fever are more susceptible to severe Covid-19.

After the discovery, Epstein and others devoted time and effort to trying to find out under what circumstances EB virus causes cancer. The relationship between the virus, other diseases, human genetics and cancer is complex, and it took decades before the medical community could accept the EB virus as a cause with confidence.

Not until 1997 did the International Agency for Research on Cancer class it as a Group 1 carcinogen, formally acknowledging its role in a variety of cancers.

The discovery of EB virus opened up a whole new field of research into cancer-causing viruses. It also raised the exciting possibility of preventing cancers through vaccination, an advance that has now been achieved in the case of human papilloma virus, which causes cervical cancer, and hepatitis B virus, which causes liver cancer.

By the time of his retirement in 1985, Epstein’s research group at the University of Bristol had developed a candidate vaccine that protected monkeys infected with EB virus against tumours, but neither it nor any other candidate has yet been successfully developed for human use.

Epstein was born in London, one of three children of Olga (nee Oppenheimer) and Mortimer Epstein. Mortimer was a writer and translator who edited The Statesman’s Yearbook for Macmillan from 1924 until his death in 1946. Olga was involved with charitable work in the Jewish community. Anthony attended St Paul’s school in west London, where the biology teacher Sidney Pask encouraged boys to go far beyond the syllabus and whose pupils also included Robert Winston and Jonathan Miller.

Epstein won a place to study medicine at Trinity College, Cambridge. He moved to Middlesex hospital medical school in wartime London to complete his training, before doing his national service in India with the Royal Army Medical Corps. He returned to work at the Middlesex hospital as assistant pathologist, conducting his own research. Thinking electron microscopy might be useful in his studies of cancer-causing viruses in chickens, he spent some time learning the new technique at the Rockefeller Institute in New York (now Rockefeller University). Not long afterwards he attended Burkitt’s lecture and began the serendipitous route to his discovery.

In 1968 he was appointed professor and head of the department of pathology at the University of Bristol, where he remained until his retirement. He moved to Oxford as a fellow of Wolfson College in 1986, becoming an honorary fellow in 2001.

An exemplary scientific good citizen, he served as foreign secretary and vice-president of the Royal Society, and sat on boards and councils for numerous national and international research organisations, including as a special representative of the director general of Unesco; he was also a patron of Humanists UK. Among his many prizes and honorary degrees, he received the international Gairdner award for biomedical research in 1988. He was appointed CBE in 1985 and knighted in 1991.

“It was a series of accidents, really,” he said of his discovery in a conversation with Burkitt they recorded for Oxford Brookes University’s oral history archive in 1991. “Lucky quirks.” Burkitt immediately responded with Louis Pasteur’s aphorism: “Chance favours the prepared mind.”

Epstein was a deeply cultured man who retained a lively interest in many subjects – particularly oriental rugs, Tibet and amphibians – until the end of his life.

He is survived by his partner, Kate Ward, by his children Susan, Simon and Michael, from his marriage to Lisbeth Knight, from whom he was separated in 1965, and who died in 2015, and by two grandchildren and two great-grandchildren.

🔔Michael Anthony Epstein, pathologist, born 18 May 1921; died 6 February 2024

Daily inspiration. Discover more photos at Just for Books…?

[52booksproject]

Book 45: The Icepick Surgeon

This week was a choice book, and last week has piqued my interest in a science history book again and who's more fun than Sam Kean? So I thought The Icepick Surgeon: Murder, Fraud, Sabotage, Piracy, and Other Dastardly Deeds Perpetrated in the Name of Science would make for a fun read. I suppose I should have paid more attention to the subtitle, because sure it had fun piracy, dinosaur wars, and money lender murders, but it also has slavery, misgendering and animal torture. Not all fun topics at all.

The first topic was piracy and that was fun, but the second was how science was entangled with slavery. Even something as abstract as Newton's Principia Mathematica used slave ship data on tides to propose the moon affected tides. Natural science was even worse and one could practically only get to Sub-Saharan Africa or South America to study plants and animals by slave ship transport and once there that was who you had to trade with for supplies. Even worse, many unscrupulous naturalists relied on slaves to gather samples, especially in the more dangerous areas. So tons of science museums' collections are built on slavery (in addition to the outright theft of property in history museums).

Other topics include the origins of forensic pathology helping solve a Harvard murder that resulted in the second and so far last Harvard graduate (and professor) to be executed, the dehumanizing experiments performed on a teenage Ted Kaczynski that undoubtedly helped turn him into the unibomber, and a overzealous yet lazy drug lab scientist swearing in court that a crushed up cashew was crack cocaine. The title refers to Walter Freeman performing lobotomies with a kitchen Icepick.

Best line: "Now, there's no truth to the rumor that Freeman dubbed the car he used on these trips "The Lobotomobile", but probably only because he didn't think of it."

Should you read this book: well, if you can stomach all the crimes against humanity and animals, it is very interesting. But there is a lot to take in. Sam Kean is always smooth, interesting reading

Art project: Here are a handful of the dinosaurs discovered during the dinosaur wars, all impossibly ranged in age and size .

[imstupidlmao]

The galaxy TV station made an agreement to boost views. Creatures from 2 planets would go primitive for one week on the each other's planets.

The aliens who volunteered were random. The humans who volunteered were random. No one from either side were obvious experts. Just eager risk takers. They were told they could bring one item and the clothes they wore. Both teams would be supplied with irreplaceable air masks and a liquid filter for necessity. As soon as they were on the ships, they would live in luxury for the week long transfer. Each ship was well equipped with stuff on their home planet, and they had no access to information about the location. When the planets came in view, the windows were covered, and they were given a mini buffet and dressed in the clothes they brought. The hanger door opened, and both teams were instructed off. The ship left immediately.

The aliens were placed in Madagascar as a mellinium old reference to some Africa dream works movie with a lion, zebra, hippo, and giraff. Madagascar had been turned into a nature preserve along with many islands. The ecosystem had been restored by lab research and anti extinction scientists. The aliens were in awe. The only one who had ever been to earth had only ever seen the sky cities and a nature reserve called Colorado. There were no sky cities in sight. This was like a whole other world. They had been set on a boarding forest. Trees, bushes, and tall grass everywhere were filled with noise fluttering from every corner. The aliens thought humans were near and looked at their other option. It was an open grassland. With trees as wide as elephants. The leaves exploded out the very top. From a distance, they could see large animals that looked like specs compared to the trees. In fear, they went into the forest, dodging the crooked skinny trunks with stabbing branches all over. Small blurs scurred past above their heads. One alien who rock climbed back home thoguht to test all the trees for weight stability. He had hoped he'd be of help if they could see from higher up.

The humans were dropped off and practically ran into the new world. A geologist from earth was stunned by the glowing gem and hollwed out rocks. They looked at what might have been an obsidian wasteland. The rocks and natural holes like Swiss cheese and green liquid pooled in the pot holes along the ground. Behind them was something of beauty. A herd of animals 3 stories tall walked with shell covered legs. Its spikey skin buldged between the shells as it bent down to drink out of the green river. They had been dumped on a large island called Dodramatkiur. It was known for its half and half nature caused by a now stagnant volcano that erupted a thousand years before. The most terrifying part was the silence. They could hear there heart beats and distant thumping of the large animals. They could hear the river slowly hitting the rocky edge. Behind where the herd had flattened the ground was a forest like place. The trees with thick leaves covered in spots spirled up the trunks. One man tried to see if he could use them as stairs but it only held his weight for a few seconds. The largest man came over and suggest everyone shake to see if it was climbable with tools of sorts. It barely budged. Joy swept through the group.

(Sorry, I suck at writing) ( The groups continue, the aliens make a shelter first, but humans start making irrigation and develope a schedule while the aliens continue exploring. Half the aliens tap out on day 5 after a threatening attack by a Fassa fossa to an alien running ahead in the group. The rest tap out on day 6 when they get lost in plains and can't find a liquid source. One human taps out due to vitamin d deficiency in the cloudy planet with a few hours a day of sun and mostly light from three moons)

Day 7: (science explanation thing about how aliens would die from heat stroke or drying out in the sun)(humans built nice home and discovered they could use green liquid to swim and clean but not consume. They also found a way to have the lightest girl safely sprint up tree and harness a rope so the group could star gaze when the largest moon set)

Day 8: (Aliens put in medical things back home and humans deconstruct their space.)(disclaimer that no one died, sorry.)

"See you next time on New and Terrifying, that's all folks!"

Take a group of aliens from any Alliance, drop them in a forest on Earth, and they will be dead in a week. Take a group of humans and put them on any Deathworld and in one week there will be a functioning tribal society.

[sainorlabs]

Venlafaxine Suppliers in India

India has long been recognized as a global pharmaceutical manufacturing hub, providing high-quality medicines at competitive prices. Among the wide array of pharmaceutical products produced in India, Venlafaxine, an antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class, holds a prominent position. With the increasing demand for mental health treatments worldwide, Indian pharmaceutical companies have stepped up to meet the supply needs for this critical drug.

The Role of Venlafaxine in Mental Health

Venlafaxine is widely prescribed for managing major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder, and panic disorder. It functions by balancing serotonin and norepinephrine levels in the brain, helping patients improve their mood and mental stability. As awareness about mental health grows, the demand for effective treatments like venlafaxine has surged globally.

India's Contribution to Venlafaxine Production

India has become a trusted source for venlafaxine due to its strong pharmaceutical infrastructure and adherence to global quality standards. Suppliers in India provide venlafaxine in various forms, including:

Tablets (extended and immediate release)

Capsules

API (Active Pharmaceutical Ingredient)

Major Indian pharmaceutical manufacturers, such as Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, and Aurobindo Pharma, have developed robust manufacturing and distribution networks, ensuring global availability of venlafaxine.

Key Factors Driving India’s Growth in Venlafaxine Supply

Cost-Effective Production India’s cost-efficient manufacturing processes, combined with access to skilled labor and advanced technologies, allow suppliers to offer venlafaxine at competitive prices without compromising quality.

Regulatory Compliance Indian pharmaceutical companies adhere to international regulatory standards, including certifications from the U.S. FDA, EMA (European Medicines Agency), and WHO-GMP. This ensures that the venlafaxine supplied from India meets stringent safety and efficacy requirements.

Research & Development Indian manufacturers invest heavily in research and development (R&D) to innovate new formulations and improve drug delivery mechanisms, making venlafaxine more effective and patient-friendly.

Export Dominance India accounts for a significant share of the global pharmaceutical export market. Indian venlafaxine suppliers serve markets in the U.S., Europe, Southeast Asia, and Africa, ensuring steady international access to the drug.

Notable Venlafaxine Suppliers in India

Sainor Labs Based in Hyderabad, Sainor Labs is a leading API manufacturer specializing in high-quality venlafaxine. The company emphasizes rigorous quality control and on-time delivery, making it a trusted name in the pharmaceutical supply chain.

Sun Pharma A global leader, Sun Pharma provides venlafaxine formulations for various therapeutic applications, catering to both domestic and international markets.

Aurobindo Pharma Known for its robust API production capabilities, Aurobindo Pharma supplies venlafaxine to several regions worldwide.

Cipla Limited Cipla has a strong foothold in mental health medications, including venlafaxine, offering products with a focus on accessibility and affordability.

Challenges and Opportunities

Despite its advantages, the Indian pharmaceutical industry faces challenges such as fluctuating raw material costs, stringent regulatory scrutiny, and competition from emerging markets. However, these hurdles also present opportunities for Indian suppliers to enhance operational efficiency, adopt innovative manufacturing techniques, and expand their global reach.

Conclusion

India’s venlafaxine suppliers, including prominent names like Sainor Labs, play a pivotal role in addressing the global demand for mental health medications. With a commitment to quality, innovation, and cost-efficiency, these companies are not only driving India’s pharmaceutical growth but also contributing to improved mental health outcomes worldwide.

As the demand for mental health treatments continues to rise, Indian pharmaceutical companies are well-positioned to lead the global venlafaxine supply, ensuring affordable and effective solutions for patients everywhere.

[nafisa661]

laboratory supply in Oman Najem Alshahab Equipment Trading L.L.C. supplies lab equipment to Dubai, UAE, and a range of regions including Kenya, Ghana, South Africa, Iran, and Iraq. Their offerings cater to diverse laboratory needs across multiple industries. The product range includes medical equipment, laboratory consumables, and hospital furniture. They provide high-quality supplies, from centrifuges and refrigerators to gauze products and wound dressings, helping laboratories and healthcare facilities meet their equipment requirements efficiently. Our product range includes laboratory consumables, medical equipment, and marine supplies. Find We supply our products in UAE, Ghana, Kenya, Doha, Qatar, South Africa & Iraq https://najemalshahab.com/lab-equipment-supply/

[shoshanews]

Apply TotalEnergies Internships Programme 2025 TotalEnergies Internships Programme 2025 Are you a recent graduate ready to kick-start your career within a globally renowned energy company? TotalEnergies Marketing South Africa offers a unique 12-month Graduate Internship Programme in 2025, located in the heart of Johannesburg. This immersive opportunity is ideal for South African graduates across multiple disciplines, from Engineering and Commerce to Environmental Science and Humanities, empowering them with hands-on industry exposure and mentorship by leading professionals. - Location: Johannesburg, South Africa - Domain: Operations | Contract Type: Internship | - Duration: 12 Months TotalEnergies, a global leader in the energy sector, is committed to fostering a sustainable future and nurturing the next generation of industry leaders. The TotalEnergies Graduate Internship Programme 2025 is designed to offer recent graduates practical work experience across various departments in alignment with their academic backgrounds. This programme focuses on providing a strong foundation in both technical and soft skills to excel in the energy sector. Graduates gain comprehensive insights into their respective fields, contributing directly to TotalEnergies’ South African operations and learning under the guidance of experienced professionals. TotalEnergies’ internship programme offers a rewarding platform for graduates, equipping them with real-world experience in a competitive industry. As a part of a high-performing team, you will have the chance to develop specialized skills, build a professional network, and contribute to an organization at the forefront of the global energy transformation. Who Should Apply? This programme is open to South African graduates with a Bachelor’s or Honours Degree in the following fields: - Engineering & Built Environment: Chemical, Electrical, Industrial, Mechanical, Metallurgical, and Process Engineering - Commerce: Finance, Accounting, Financial Management, Economics, Supply Chain, Logistics, and Transport Management - Science & Technology: Applied Chemistry, Statistical Sciences, Mathematics, Computer Science, Data Analytics, Environmental Science, and Geography - Humanities: Social Work, Human Resources, and Industrial Psychology - Law: Bachelor of Laws (LLB) - Governance: Compliance, Marketing Management, and Governance Key Programme Highlights and Activities Interns joining the TotalEnergies Graduate Internship Programme in Johannesburg will experience a supportive, dynamic, and challenging work environment. Each intern will: - Collaborate with seasoned professionals and engage in day-to-day tasks relevant to their department. - Gain valuable insights into operations, technology, and sustainability efforts within a leading energy firm. - Enhance skills applicable to diverse industries, from commerce and engineering to environmental sustainability. - Contribute to strategic projects that align with TotalEnergies’ vision and corporate social responsibility. Eligibility Requirements To qualify, applicants must: - Be South African citizens with a completed Bachelor’s or Honours Degree. - Possess a recently updated CV, valid ID copy, qualification certificates, and academic records. - Have less than one year of work experience. Required Documents Candidates are required to submit the following: - Updated CV: Showcasing academic background and skills. - ID Copy: Proof of South African citizenship. - Qualification Documents: Verified copies of degree certificates. - Academic Record: An official transcript of grades. SEE ALSO: Ampath Laboratories Lab Assistants Learnerships 2024 How to Apply? Click Here to Apply Read the full article

[janetushar1]

IoT in Healthcare Market to Hit $571.90 Billion by 2032

The global IoT in Healthcare Market was valued at USD 91.76 Billion in 2024 and it is estimated to garner USD 571.90 Billion by 2032 with a registered CAGR of 25.7% during the forecast period 2024 to 2032.

The report throws light on the competitive scenario of the global IoT in Healthcare Market to know the competition at global levels. Market experts also provided the outline of each leading player of the global IoT in Healthcare Market for the market, considering the key aspects such as the areas of operation, production, and product portfolio. In addition, the companies in the report are studied based on vital factors such as company size, market share, market growth, revenue, production volume, and profit.

The global IoT in Healthcare Market is fragmented with various key players. Some of the key players identified across the value chain of the global IoT in Healthcare Market include Cisco Systems Inc., Microsoft Corporation, IBM Corporation, SAP SE, Qualcomm Life, Inc., Honeywell Life Care Solutions, GE Healthcare, Siemens Healthineers, Medtronic, Philips, Honeywell Life Care Solutions, Boston Scientific, Johnson & Johnson, BIOTRONIK, Omron, AgaMatrix, STANLEY Healthcare, AliveCor, iHealth Lab, and Welch Allyn. etc. Considering the increasing demand from global markets various new entries are expected in the IoT in Healthcare Market at regional as well as global levels.

Download IoT in Healthcare Market Sample Report PDF: https://www.vantagemarketresearch.com/iot-in-healthcare-market-1232/request-sample

Top Competitors:

Cisco Systems Inc., Microsoft Corporation, IBM Corporation, SAP SE, Qualcomm Life, Inc., Honeywell Life Care Solutions, GE Healthcare, Siemens Healthineers, Medtronic, Philips, Honeywell Life Care Solutions, Boston Scientific, Johnson & Johnson, BIOTRONIK, Omron, AgaMatrix, STANLEY Healthcare, AliveCor, iHealth Lab, and Welch Allyn.

Understanding the Industry's Growth, has released an Updated report on the IoT in Healthcare Market. The report is mixed with crucial market insights that will support the clients to make the right business decisions. This research will help new players in the global IoT in Healthcare Market to sort out and study market needs, market size, and competition. The report provides information on the supply and market situation, the competitive situation and the challenges to the market growth, the market opportunities, and the threats faced by the major players.

Regional Analysis

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/iot-in-healthcare-market-1232/0

Full Analysis Of The IoT in Healthcare Market:

Key findings and recommendations point to vital progressive industry trends in the global IoT in Healthcare Market, empowering players to improve effective long-term policies.

The report makes a full analysis of the factors driving the development of the market.

Analyzing the market opportunities for stakeholders by categorizing the high-growth divisions of the market.

Questions answered in the report

-Who are the top five players in the global IoT in Healthcare Market?

-How will the global IoT in Healthcare Market change in the next five years?

-Which product and application will take the lion's share of the global IoT in Healthcare Market?

-What are the drivers and restraints of the global IoT in Healthcare Market?

-Which regional market will show the highest growth?

-What will be the CAGR and size of the global IoT in Healthcare Market during the forecast period?

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/iot-in-healthcare-market-1232

Reasons to Purchase this IoT in Healthcare Market Report:

-Analysis of the market outlook on current trends and SWOT analysis.

-The geographic and country level is designed to integrate the supply and demand organizations that drive industry growth.

-IoT in Healthcare Industry dynamics along with market growth opportunities in the coming years.

-IoT in Healthcare Market value (million USD) and volume (million units) data for each segment and sub-segment.

1 year consulting for analysts along with development data support in Excel. Competitive landscape including market share of major players along with various projects and strategies adopted by players in the last five years.

Market segmentation analysis including qualitative and quantitative analysis including the impact on financial and non-economic aspects.

Complete company profiles that include performance presentations, key financial overviews, current developments, SWOT analyzes and strategies used by major IoT in Healthcare Market players.

Check Out More Reports

Global Proteomics Market:  Report Forecast by 2032

Global 3D Cell Culture Market: Report Forecast by 2032

Global Payment Orchestration Platform Market: Report Forecast by 2032

Global Cannabis Edibles Market: Report Forecast by 2032

Global Whey Protein Market: Report Forecast by 2032

[swldx]

Voice of America 0339 1 Nov 2024

6080Khz 0328 1 NOV 2024 - VOICE OF AMERICA (UNITED STATES OF AMERICA) in ENGLISH from MOPENG HILL. SINPO = 45333. English, "Daybreak Africa" in progress fb news @0330z anchored by Alexis Strope. § Most of the North Korean troops sent to Russia are now deployed near the Ukrainian border and are expected to join the fight against Ukraine “in the coming days,” according to top U.S. and South Korean diplomats and military officials. “We now assess that there are some 10,000 North Korean soldiers in total in Russia, and the most recent information indicates that as many as 8,000 of those North Korean forces have been deployed to the Kursk region,” U.S. Secretary of State Antony Blinken said Thursday. § Five people were killed in northern Israel by projectiles fired from Lebanon, including an Israeli farmer and four foreign workers, authorities said. Lebanon said Israeli strikes killed at least eight people, including six health workers in the country’s south. Meanwhile, Palestinian officials said an Israeli attack in the occupied West Bank killed three people. The Israeli military said it also struck Hezbollah weapons depots and bases in Syria, where it claimed the militant group recently began storing weapons along the Syria-Lebanon border to smuggle them into Lebanon. And in Gaza, at least 46 Palestinians were killed Thursday in Israeli military strikes across the enclave, primarily in the territory’s north, where one attack hit a hospital, local health officials said. The Israeli military accused Hamas of using the hospital for military purposes and said “dozens of terrorists” have been hiding there, which health officials and Hamas denied. § Crews searched for bodies in stranded cars and sodden buildings Thursday as residents salvaged what they could from their ruined homes following monstrous flash floods in Spain that claimed at least 158 lives, with 155 deaths confirmed in the eastern Valencia region alone. § 100s of Ecuadoreans hit the streets for anti-government protests amid widespread power cuts. Ecuador's worst drought in over 60 years has plunged the hydropower-dependent country into an energy crisis as diminished reservoirs leave hydroelectric dams offline, pushing the government to impose power cuts to limit the strain on electricity supplies. § The European Union is investigating Chinese online retailer Temu over suspicions it's failing to prevent the sale of illegal products, the 27-nation bloc's executive arm said on Thursday. Temu started entering Western markets only in the past two years and has grown in popularity by offering cheap goods, from clothing to home products, that are shipped from sellers in China. The company, owned by Pinduoduo Incorporated, a popular e-commerce site in China, now has 92 million users in the EU. § Canadian police dismantled what they said Thursday is the largest, most sophisticated illicit drug “super lab” in the country. The Royal Canadian Mounted Police believe organized crime ran the operation where there was mass-production and distribution of fentanyl and methamphetamine across Canada and internationally. @0335z "International Edition" begins. MLA 30 amplified loop (powered w/8 AA rechargeable batteries ~10.8vdc), JRC NRD-535D. 100kW, beamAz 350°, bearing 84°. Received at Plymouth, MN, United States, 14087KM from transmitter at Mopeng Hill. Local time: 2228.

[hotzimbabwejobs]

Calling all recent graduates! Africa University needs Laboratory Scientist Graduate Interns! - October 2024

The Opportunity: Africa University’s ZENTO project is seeking passionate recent graduates for a Laboratory Scientist internship program. You’ll gain valuable experience while contributing to important research! Responsibilities: Maintain lab protocols and safety standards. Identify mosquitoes. Conduct lab assays (molecular & immune detection). Manage lab supplies and inventory. Prepare…

[pharmatechy]

Top 10 Pharmaceutical Companies in India

* The Top 10 Pharmaceutical Companies in India are ranked by their revenue and market capitalization.

* India is the largest provider of generic medicines, holding a market share of 25% of the global supply by volume and meeting 61% of the vaccine requirement worldwide.

* Indian Pharmaceutical companies also supply 81% of antiretroviral medications (HIV/AIDS) in the worldwide markets.

* The international pharmaceutical market is anticipated to surpass USD 1.27 trillion by 2023. India is one most suitable states in this worldwide pharma market. India provides more than 55% of the worldwide purpose for different vaccines and 45% of the demand for generic medicines in the United States. India’s pharmaceuticals demanded to expand at 11% CAGR during 2023 to reach 33 Billion US dollars.

1. Sun Pharmaceutical Industries Ltd * Sun Pharmaceutical Industries Ltd is an Indian multinational pharmaceutical company founded by Dilip Shanghvi in 1983, Vapi, Headquarters Goregaon, Mumbai, India, And Subsidiaries of Ranbaxy Laboratories, etc. It produces and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India also the United States. It provides formulations in psychiatry, cardiology, dialectology, neurology, and gastroenterology. * Sun Pharma supplies APIs such as etodolac, clorazepate, carbamazepine, warfarin, anti-cancer drugs, peptides, steroids, sex hormones, etc. It supplies more than 2000 formulations and also exports to various other countries. * The main features of Sun Pharma are research and development facilities and its own APIs. It supplies more than 2000 formulations and also exports to various other countries. The main features of Sun Pharmaceuticals are research and development facilities and its own APIs.

2. Dr Reddy’s Laboratories Ltd Dr Reddy’s Laboratories is an Indian multinational pharmaceutical company founded by Kallam Anji Reddy in 1984, in Hyderabad, India. The company produces pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and other countries and more than 195 drugs, and 65 APIs for drug, and biotechnology products. DRL has six API units(CTO)and four Formulation(FTO) manufacturing plants across India. Its main focus research and development centres are Integrated Product Development Organization (IPDO) and Custom Pharmaceutical Services (CPS) located in Hyderabad, India.

3. Divi’s Laboratories Ltd Divis Labs is an Indian pharmaceutical company founded by Murali Divi in 1990, in Hyderabad, India. It manufactures APIs, Intermediates, and Nutraceutical ingredients. Divis Labs have three manufacturing units located at Chouttal, Hyderabad, Chippada, Andhra Pradesh, and 3 Research and development centres. The Company exports the products to the USA, Europe, Japan, South Africa, Australia, and the Philippines.

4. Cipla Ltd * Cipla is an Indian multinational pharmaceutical company founded by Khwaja Abdul Hamied in 1935, with Headquarters in Mumbai, India, And supplies top-quality generic medicines in India. * The company supplies a wide range of medicines. It has a prominent position in the Indian market and global market and in more than 150 countries. The company provides quality products worldwide received approvals from major regulatory agencies and more than 2000 formulations cover areas like neurology and nephrology. It has a global focus on the important markets of India, the US, and South Africa.

5. Aurobindo Pharma Ltd * Aurobindo Pharma is an Indian pharmaceutical company founded by Nityananda Reddy started operations in 1988 with a single unit manufacturing Synthetic Penicillin at Pondicherry and became a public company in 1992 headquartered in HITEC City, Hyderabad, India. The company has provided key therapeutics like cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-Allergics. APL exports products to more than 160 nations in the world. Aurobindo Pharma has production, research, and development and Subsidiary units are Novagen Pharma, AuroZymes Ltd, etc.

6 Torrent Pharmaceuticals Ltd * Torrent Pharma is an Indian pharmaceutical company founded by Uttambhai NathalalMehta in 1959 Headquarters in Ahmedabad, India. started as Trinity Laboratories Ltd, and renamed Torrent Pharmaceuticals Ltd, nowadays. It is ranked the leader in the therapeutic sector of women’s health care, cardiovascular, CNS, gastrointestinal, diabetology, oncology, gynaecology, and anti-infective. They have first-class manufacturing units, R & D facilities, and a prevalent international presence in more than 50 nations. The company had procured Elder Pharma’s Indian company, Zyg Pharma, the API plant of Glochem Industries, Unichem’s Sikkim Plant, Bio-Pharm Inc., generic pharmaceuticals, etc. 7. Lupin Ltd * Lupin is a multinational pharmaceutical company founded by Desh Bandhu Gupta in 1968 in Mumbai, India. A large range of products like Branded & Generic Formulations, Biotechnology Products, APIs, and manufacturing centres are across India, Japan, Brazil, Mexico, and the United States. Subsidiaries are Novel Laboratories, Polynova Industries, and GAVIS Pharmaceuticals. The company is in the treatment areas of Non-Steroidal Anti-Inflammatory Drugs, Cardiovascular, Gynaecology, Asthma, Paediatric, Diabetology, Gastro-Intestinal, and Anti-Infective drugs, Anti-TB and Cephalosporins sectors. The company has moved around more than 100 countries. It supplies top-quality medications. The company is in the treatment areas of Non-Steroidal Anti-Inflammatory Drugs, Cardiovascular, Gynaecology, Asthma, Paediatric, Diabetology, Gastro-Intestinal, and Anti-Infective drugs, Anti-TB and Cephalosporins sectors. The company has moved around more than 100 countries. It supplies top-quality medications.

8. Zydus Cadila Healthcare Ltd * Zydus Cadila is a fully integrated Indian Pharmaceutical company founded by Ramanbhai B. Patel in 1952 in Ahmedabad, Gujarat India. It provides Active pharmaceutical ingredients, formulations, and animal healthcare products to wellness products. The company’s research and development facilities are in Gujarat, Maharashtra, Goa, Himachal, and Sikkim as well as research units in the US and Brazil. It has 1400 researchers across 20 sites, working on medicines and exploring various ideas from NCEs to vaccines, and bio-similar products. The company’s global business has regulated markets in the United States, Europe, South Africa, Latin America, and also 30 other national markets in the world.

9. Abbott Pharma India Ltd * Abbott India Limited is a Pharmaceutical company founded by Dr Wallace Calvin Abbott in 1944, in Mumbai, India, and a subsidiary of Abbott Laboratories United States. It manufactures pharmaceutical drugs, therapeutics for Women’s Health, Neurology, Thyroid, Gastroenterology, Anti-Infective, Diabetes, Urology, Pain, Vitamins, etc., and a plant at Verna, Goa. It has to produce high-quality formulations, branded generic pharmaceuticals, diagnostics, medical devices, and nutrition.

10. Alkem Laboratories Ltd * Alkem Laboratories is a Pharmaceutical company founded by Samprada Singh in 1973, in Mumbai, India. It provides quality branded generics, generic medications, APIs, and nutraceuticals in India, and more than 60 countries worldwide. Alkem has been ranked as the No.1 Anti-infective company in India for more than ten years and also has therapeutic segments for gastrointestinal, Vitamins, Minerals, Nutrients, and pain management.

Conclusion: * These are the Top 10 Pharmaceutical Companies in India and supply worldwide Pharmaceutical Products. The ranking of the Pharma companies changes every year and depends upon the revenue and Market Capitalizations.